Quick Answer
United Health Products, Inc. reported Total Revenue of $0.00 for fiscal year 2024.
United Health Products, Inc. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $0.00 | $0.00 -100.0% |
$37.5K +63459.3% |
$59.00 -90.8% |
$643.00 -86.9% |
$4.9K -85.9% |
| Net Income | -$2.00M +23.7% |
-$2.62M -55.5% |
-$1.69M +94.5% |
-$30.55M -94.4% |
-$15.71M -138.0% |
-$6.60M -22.2% |
| Diluted EPS | -$0.01 +0.0% |
-$0.01 | — | — | — | — |
| Total Assets | $270.0K -5.2% |
$284.6K -18.8% |
$350.5K +1208.0% |
$26.8K -87.7% |
$217.1K +132.3% |
$93.5K -17.5% |
| Cash and Equivalents | — | — | $13.4K -38.6% |
$21.8K -52.7% |
$46.1K +177.2% |
$16.6K -46.8% |
| Stockholders Equity | -$2.44M -42.6% |
-$1.71M +17.0% |
-$2.06M -80.8% |
-$1.14M -19.8% |
-$953.3K -5.5% |
-$903.8K -499.8% |
| R&D Expense | $355.9K -40.6% |
$598.8K -4.1% |
$624.6K +163.0% |
$237.5K -3.2% |
$245.2K -63.2% |
$666.4K +766.0% |
| Operating Income | -$2.01M +17.3% |
-$2.43M +13.4% |
-$2.80M +90.6% |
-$29.80M -100.7% |
-$14.85M -143.7% |
-$6.09M -221.3% |
| Gross Profit | — | $0.00 -100.0% |
$18.9K +55358.8% |
$34.00 -92.4% |
$448.00 -87.6% |
$3.6K -71.4% |
| Shares Outstanding | 252.41M +3.1% |
244.78M +6.0% |
230.87M +1.0% |
228.67M +20.8% |
189.36M +6.3% |
178.06M +3.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $0.00 | — | — |
| Net Income | September 30, 2025 | -$285.6K | +6.0% | +9.4% |
| Diluted EPS | September 30, 2025 | $0.00 | — | — |
| Total Assets | September 30, 2025 | $94.3K | -37.4% | +15.7% |
| Cash and Equivalents | March 31, 2023 | $32.0K | -3.0% | +138.9% |
| Stockholders Equity | September 30, 2025 | -$3.34M | -58.2% | -5.3% |
| R&D Expense | September 30, 2025 | $25.3K | -61.5% | -68.7% |
| Operating Income | September 30, 2025 | -$233.2K | +40.5% | +13.1% |
| Gross Profit | September 30, 2023 | $0.00 | -100.0% | -100.0% |
| Shares Outstanding | September 30, 2025 | 258.69M | +3.6% | +0.6% |
- United Health Products, Inc. reported Total Revenue of $0.00 for fiscal year 2024.
- United Health Products, Inc. reported Net Income of -$2.00 million for fiscal year 2024.
- United Health Products, Inc. showed an increase of +23.7% in Net Income compared to the prior fiscal year.
- United Health Products, Inc. reported Diluted EPS of $0.01 per share (loss) for fiscal year 2024.
- United Health Products, Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- United Health Products, Inc. reported Total Assets of $270.0 thousand for fiscal year 2024.
- United Health Products, Inc. showed a decrease of -5.2% in Total Assets compared to the prior fiscal year.
- United Health Products, Inc. reported Cash and Equivalents of $13.4 thousand for fiscal year 2022.
- United Health Products, Inc. showed a decrease of -38.6% in Cash and Equivalents compared to the prior fiscal year.
- United Health Products, Inc. reported Stockholders Equity of -$2.44 million for fiscal year 2024.
- United Health Products, Inc. showed a decrease of -42.6% in Stockholders Equity compared to the prior fiscal year.
- United Health Products, Inc. reported R&D Expense of $355.9 thousand for fiscal year 2024.
- United Health Products, Inc. showed a decrease of -40.6% in R&D Expense compared to the prior fiscal year.
- United Health Products, Inc. reported Operating Income of -$2.01 million for fiscal year 2024.
- United Health Products, Inc. showed an increase of +17.3% in Operating Income compared to the prior fiscal year.
- United Health Products, Inc. reported Gross Profit of $0.00 for fiscal year 2023.
- United Health Products, Inc. showed a decrease of -100.0% in Gross Profit compared to the prior fiscal year.
- United Health Products, Inc. reported Shares Outstanding of 252.41 million shares for fiscal year 2024.
- United Health Products, Inc. showed an increase of +3.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: